Conmed (CNMD) Net Cash Flow Growth (5y) (2015 - 2026)
Conmed (CNMD) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Conmed | 1.54 Bn | 1.51 Bn | 197.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.38% |
| Mar 31, 2026 | -19.92% |
| Dec 31, 2025 | 16.89% |
| Sep 30, 2025 | 59.44% |
| Jun 30, 2025 | -18.31% |
| Mar 31, 2025 | 117.82% |
| Dec 31, 2024 | -18.88% |
| Sep 30, 2024 | 1.51% |
| Jun 30, 2024 | -32.20% |
| Mar 31, 2024 | 10.61% |
| Dec 31, 2023 | 9.19% |
| Sep 30, 2023 | -11.21% |
| Jun 30, 2023 | -16.46% |
| Mar 31, 2023 | 25.59% |
| Dec 31, 2022 | 11.10% |
| Sep 30, 2022 | -53.37% |
| Jun 30, 2022 | 50.31% |
| Mar 31, 2022 | -8.52% |
| Dec 31, 2021 | -47.46% |
| Sep 30, 2021 | -44.53% |